Knowledge and analyses

Amgros collects knowledge, and we then combine, enrich and analyse it. Knowledge is what drives our business, and we want to share our knowledge and make it available to all of our stakeholders. On this page, you'll find an overview of our analyses and reports. We regularly update the page with new publications.

Figures for 2021

In 2021, the regions procured medicines for hospitals via Amgros costing almost DKK 9.4 bn. Expenditure on medicines rose by approx. DKK 108 million, corresponding to a 1.2% increase compared with 2020.

In the same period, the amount of pharmaceuticals procured by the regions rose by almost 4%. This means that the average purchase price has fallen.

The total savings obtained by the regions compared with the official list prices, rose from 40% to 43%.

Like last year, the hospital sector spent most on the product Darzalex in 2021. This is a product to treat bone marrow cancer.

Source: Amgros' Market Surveillance report for Q4 2021(only available in Danish).

List of all articles from Amgros

Read more

Knowledge and analyses

Pharmaceuticals in the pipeline in the EMA

We monitor and register applications from pharmaceutical companies to the European Medicines Agency (EMA): Both applications for marketing authorisations for new pharmaceuticals, as well as applications for changes to existing marketing authorisations such as extensions of indications and other extensions.

Knowledge and analyses


At Amgros, we happily share our knowledge and insights with everyone with an interest in the Danish healthcare sector. On this page, we've collated the latest news, feature articles and interviews from our world.


Karen Torgny

Senior communication specialist

I’m responsible for overall communication at Amgros, including PR. And I help to ensure that we communicate with the surrounding world in an open and engaging manner.